SCHEMBL6170467

SCHEMBL6170467

CCOC(=O)c1ccc([N+](=O)[O-])c(N(Cc2ccc(Cl)cc2Cl)C(C)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 5/20 0.44
POLB P06746 3/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 5/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
PKM P14618 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
LMNA P02545 3/20 0.42
PTGER4 P35408 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170317 0.92 KMT2A (0.50) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6170389 0.89 KMT2A (0.48) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6170369 0.84 KMT2A (0.47) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6168812 0.83 KMT2A (0.47) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6170395 0.83 KMT2A (0.48) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6169083 0.81 MAPT (0.49) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6169177 0.81 MAPT (0.50) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6171240 0.80 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6169314 0.80 KMT2A (0.45) KMT2AMEN1ALDH1A1POLBKDM4E
SCHEMBL6167784 0.80 KMT2A (0.47) KMT2AMEN1ALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed